Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Indian Journal of Pediatrics
Erschienen in: Indian Journal of Pediatrics 10/2010

01.10.2010 | Symposium on Pediatric Rheumatology-II

Outcome Measures in Pediatric Rheumatology

verfasst von: Sujata Sawhney, Manjari Agarwal

Erschienen in: Indian Journal of Pediatrics | Ausgabe 10/2010

Einloggen, um Zugang zu erhalten

Abstract

Children with rheumatologic disorders need periodic systematic evaluation of their disease status so that all aspects of the child’s life that are affected can be adequately assessed. The commonest rheumatologic disease that afflicts children is Juvenile Idiopathic Arthritis (JIA). The child with JIA should have several domains assessed at regular intervals. These outcome measures include the physical, functional and the quality of life assessment measures. No single measure can capture the full impact of the disease on the child’s life. This article highlights the key outcome measures in a child with JIA and introduces the readers to several disease measurement tools that have been developed for assessment of outcome for the child with JIA.
Literatur
1.
Finster M, Wood M. The Apgar score has survived the test of time. Anesthesiology. 2005;102(4):855–7.CrossRefPubMed
2.
The International Expert Committee. International expert committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009;32(7):1327–34.CrossRef
3.
Ringold S, Wallace CA. Measuring clinical response and remission in juvenile idiopathic arthritis. Curr Opin Rheumatol. 2007;19(5):471–6.CrossRefPubMed
4.
Duffy CM. Measurement of health status, functional status, and quality of life in children with juvenile idiopathic arthritis: clinical science for the pediatrician. Pediatr Clin North Am. 2005;52(2):359–72.CrossRefPubMed
5.
Gill TM, Feinstein AR. A critical appraisal of the quality of quality-of-life measurements. JAMA. 1994;272(8):619–26.CrossRefPubMed
6.
Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum. 1997;40(7):1202–9.PubMed
7.
Brunner HI, Lovell DJ, Finck BK, Giannini EH. Preliminary definition of disease flare in juvenile rheumatoid arthritis. J Rheumatol. 2002;29(5):1058–64.PubMed
8.
Wallace CA, Ruperto N, Giannini E, Childhood Arthritis and Rheumatology Research Alliance, Pediatric Rheumatology International Trials Organization, Pediatric Rheumatology Collaborative Study Group. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol. 2004;31(11):2290–4.PubMed
9.
Ringold S, Seidel KD, Koepsell TD, Wallace CA. Inactive disease in polyarticular juvenile idiopathic arthritis: current patterns and associations. Rheumatology. 2009;48(8):972–7.CrossRefPubMed
10.
Lurati A, Salmaso A, Gerloni V, Gattinara M, Fantini F. Accuracy of Wallace criteria for clinical remission in juvenile idiopathic arthritis: a cohort study of 761 consecutive cases. J Rheumatol. 2009;36(7):1532–5.CrossRefPubMed
11.
Russo RA, Katsicas MM. Clinical remission in patients with systemic juvenile idiopathic arthritis treated with anti-tumor necrosis factor agents. J Rheumatol. 2009;36(5):1078–82.CrossRefPubMed
12.
van der Heijde DM, van’t Hof M, van Riel PL, van de Putte LB. Development of a disease activity score based on judgment in clinical practice by rheumatologists. J Rheumatol. 1993;20:579–81.PubMed
13.
Fransen J, van Riel PL. The disease activity score and the EULAR response criteria. Rheum Dis Clin North Am. 2009;35(4):745–57. vii–viii.CrossRefPubMed
14.
Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Kerstens PJ, et al. DAS-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis. Ann Rheum Dis. 2010;69(1):65–9.CrossRefPubMed
15.
Consolaro A, Ruperto N, Bazso A, et al. Pediatric Rheumatology International Trials Organisation. Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Rheum. 2009;15;61(5):658–66.CrossRef
16.
Viola S, Felici E, Magni-Manzoni S, et al. Development and validation of a clinical index for assessment of long-term damage in juvenile idiopathic arthritis. Arthritis Rheum. 2005;52(7):2092–102.CrossRefPubMed
17.
Sarma PK, Misra R, Aggarwal A. Outcome in patients with enthesitis related arthritis (ERA): juvenile arthritis damage index (JADI) and functional status. Pediatr Rheumatol Online J. 2008;6:18.CrossRefPubMed
18.
Poznanski AK, Hernandez RJ, Guire KE, Bereza U, Garn SM. Carpal length in children: a useful measurement in the diagnosis of rheumatoid arthritis and some congenital malformation syndromes. Radiology. 1978;129:661–8.PubMed
19.
Magni-Manzoni S, Rossi F, Pistorio A, et al. Prognostic factors for radiographic progression, radiographic damage, and disability in juvenile idiopathic arthritis. Arthritis Rheum. 2003;48:3509–17.CrossRefPubMed
20.
Van Rossum MA, Boers M, Zwinderman AH, et al. Dutch Juvenile Idiopathic Arthritis Study Group. Development of a standardized method of assessment of radiographs and radiographic change in juvenile idiopathic arthritis: introduction of the Dijkstra composite score. Arthritis Rheum. 2005;52(9):2865–72.CrossRefPubMed
21.
Rossi F, Di Dia F, Galipò O, et al. Use of the Sharp and Larsen scoring methods in the assessment of radiographic progression in juvenile idiopathic arthritis. Arthritis Rheum. 2006;15; 55(5):717–23.CrossRef
22.
Bertamino M, Rossi F, Pistorio A, et al. Development and initial validation of a radiographic scoring system for the hip in juvenile idiopathic arthritis. J Rheumatol. 2010;37(2):432–9.CrossRefPubMed
23.
Malattia C, Damasio MB, Magnaguagno F, et al. Magnetic resonance imaging, ultrasonography, and conventional radiography in the assessment of bone erosions in juvenile idiopathic arthritis. Arthritis Rheum. 2008;59(12):1764–72.CrossRefPubMed
24.
Olech E, Crues 3rd JV, Yocum DE, Merrill JT. Bone marrow edema is the most specific finding for rheumatoid arthritis (RA) on noncontrast magnetic resonance imaging of the hands and wrists: a comparison of patients with RA and healthy controls. J Rheumatol. 2010;37(2):265–74.CrossRefPubMed
25.
Singh G, Athreya BH, Fries JF, Goldsmith DP. Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum. 1994;37(12):1761–9.CrossRefPubMed
26.
Dempster H, Porepa M, Young N, Feldman BM. The clinical meaning of functional outcome scores in children with juvenile arthritis. Arthritis Rheum. 2001;4(8):1768–74.CrossRef
27.
Lovell DJ, Howe S, Shear E, et al. Development of a disability measurement tool for juvenile rheumatoid arthritis. The Juvenile Arthritis Functional Assessment Scale. Arthritis Rheum. 1989;32(11):1390–5.CrossRefPubMed
28.
Howe S, Levinson J, Shear E, et al. Development of a disability measurement tool for juvenile rheumatoid arthritis. The Juvenile Arthritis Functional Assessment Report for Children and their Parents. Arthritis Rheum. 1991;34(7):873–80.CrossRefPubMed
29.
Landgraf JM, Abetz L, Ware JE. In the CHQ user’s manual. 1st ed. Boston: The Health Institute, New England Medical Center; 1996.
30.
Oliveira S, Ravelli A, Pistorio A, et al. The Pediatric Rheumatology International Trials Organization (PRINTO). Proxy reported health related quality of life of patients with juvenile idiopathic arthritis: the pediatric rheumatology international trials organization quality of life cohort study. Arthritis Rheum. 2007;57:35–43.CrossRefPubMed
31.
Prince FH, Geerdink LM, Borsboom GJ, et al. Major improvements in health-related quality of life during the use of etanercept in patients with previously refractory juvenile idiopathic arthritis. Ann Rheum Dis. 2010;69(1):138–42.CrossRefPubMed
32.
Duffy CM, Arsenault L, Duffy KNW, et al. The juvenile arthritis quality of life questionnaire—development of a new responsive index for juvenile rheumatoid arthritis and juvenile spondyloarthritides. J Rheumatol. 1997;24:738–46.PubMed
33.
Varni JW, Seid M, Rode CA. The Peds QL: measurement model for the pediatric quality of life inventory. Med Care. 1999;37:126–39.CrossRefPubMed
34.
Allaire SH, DeNardo BS, Szer IS, Meenan RF, Schaller JG. The economic impacts of juvenile rheumatoid arthritis. J Rheumatol. 1992;19(6):952–5.PubMed
35.
Minden K, Niewerth M, Listing J, et al. The economic burden of juvenile idiopathic arthritis-results from the German pediatric rheumatologic database. Clin Exp Rheumatol. 2009;27(5):863–9.PubMed
36.
Thornton J, Lunt M, Ashcroft DM, et al. Costing juvenile idiopathic arthritis: examining patient-based costs during the first year after diagnosis. Rheumatology. 2008;47(7):985–90.CrossRefPubMed
37.
Haapasaari J, Kautiainen HJ, Isomäki HA, Hakala M. Etanercept does not essentially increase the total costs of the treatment of refractory juvenile idiopathic arthritis. J Rheumatol. 2004;31(11):2286–9.PubMed
Metadaten
Titel
Outcome Measures in Pediatric Rheumatology
verfasst von
Sujata Sawhney
Manjari Agarwal
Publikationsdatum
01.10.2010
Verlag
Springer-Verlag
Erschienen in
Indian Journal of Pediatrics / Ausgabe 10/2010
Print ISSN: 0019-5456
Elektronische ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-010-0208-9

Weitere Artikel der Ausgabe 10/2010

Indian Journal of Pediatrics 10/2010 Zur Ausgabe

Clinical Brief

Peroxisomal Disorder-Unusual Presentation as Failure to Thrive in Early Infancy

Symposium on AIIMS Protocols in Neonatology-I

Editorial

Clinical Brief

Childhood Chronic Myeloid Leukemia with Monocytosis

Symposium on AIIMS Protocols in Neonatology-I

Hypoglycemia in the Newborn

Clinical Briefs

Accidental Inorganic Mercury Chloride Poisoning in a 2-Year Old Child

Symposium on Rheumatology

Pediatric Vasculitides: A Generalists Approach

Neu im Fachgebiet Pädiatrie

Kinder mit anhaltender Sinusitis profitieren häufig von Antibiotika

30.04.2024 Rhinitis und Sinusitis Nachrichten

Persistieren Sinusitisbeschwerden bei Kindern länger als zehn Tage, ist eine Antibiotikatherapie häufig gut wirksam: Ein Therapieversagen ist damit zu über 40% seltener zu beobachten als unter Placebo.

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise